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induced Lung Inflammation: Implications in Pathogenesis of
COPD
Saravanan Rajendrasozhan, Se-Ran Yang, Indika Edirisinghe, Hongwei Yao, David
Adenuga, and Irfan Rahman
Department of Environmental Medicine, Lung Biology and Disease Program, University of
Rochester Medical Center, Rochester, NY, USA
Abstract
Oxidative stress has been implicated in the pathogenesis of several inflammatory lung disorders
including chronic obstructive pulmonary disease (COPD) due to its effect on pro-inflammatory gene
transcription. Cigarette smoke-mediated oxidative stress activates NF-κB-dependent transcription of
pro-inflammatory mediators either through activation of inhibitor κB-α kinase (IKK) and/or the
enhanced recruitment and activation of transcriptional co-activators. Enhanced NF-κB-co-activator
complex formation results in targeted increase in chromatin modifications, such as histone acetylation
leading to inflammatory gene transcription. NF-κB-dependent gene expression, at least in part, is
regulated by changes in deacetylases such as histone deacetylases (HDACs) and sirtuins. Cigarette
smoke and oxidants also alter the levels/activity of HDAC by post-translational modifications and
in doing so further induces gene expression of pro-inflammatory mediators. In addition, cigarette
smoke/oxidants can reduce glucocorticoid sensitivity by attenuating HDAC2 activity and expression,
which may account for the glucocorticoid insensitivity in patients with COPD. Understanding the
mechanisms of NF-κB regulation, and the balance between histone acetylation and deacetylation
may lead to the development of novel therapies based on the pharmacological manipulation of IKK
and deacetylases in lung inflammation and injury.
Keywords
COPD; reactive oxygen species; histone acetylation; HDAC; sirtuins
INTRODUCTION
Biological systems are continuously exposed to oxidants either generated endogenously by
metabolic reactions (mitochondrial electron transport during respiration, during activating
phagocytes) or exogenously (air pollutants or cigarette smoke). The great external surface area
(1–2 m2) of the human airway epithelium (300 million alveoli), alveolar ducts (14 million),
capillary segments (280 billion) plus its direct contact with the high-oxygen environment for
gas exchange between air and blood (alveolar and alveolar-capillary surface area=40 to 80
square meters) makes the lung a major target for oxidative injury from reactive oxygen species
(ROS) and free radicals (5,71,73). Inflammation is an important protective response to cellular/
tissue injury. The purpose of this process is to destroy and remove the injurious agent and
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injured tissues, thereby promoting tissue repair. When this crucial and normally beneficial
response occurs in an uncontrolled manner, the result is excessive cellular/tissue damage that
results in chronic inflammation and destruction of normal tissue. ROS, such as superoxide
anion (O2•-) liberated by phagocytes recruited to sites of inflammation, are proposed to be a
major cause of the cell and tissue damage associated with many chronic inflammatory diseases
such as asthma and chronic obstructive pulmonary disease (COPD) (58,72). Increased levels
of ROS have been implicated in initiating the lung inflammatory responses through the
activation of redox sensitive transcription factor, nuclear factor-kappa B (NF-κB), and
chromatin remodeling (histone acetylation/deacetylation), which regulate the gene expression
of pro-inflammatory mediators (70) (Figure 1). In this review, we present an overview of redox
regulation of NF-κB and describe the current evidence on involvement of histone deacetylase
in oxidant-mediated lung inflammation.
OXIDATIVE STRESS
Aerobic metabolism is the major source of ROS and reactive nitrogen (RNS) species, which
are essentially the byproducts of normal oxygen metabolism. Biological systems are capable
of forming highly reactive moieties, both free radicals and non-radicals. These biologically
active species participate in normal cell functions by serve in host defense and also in cell
signaling as messenger molecules of the autocrine or paracrine system (77), but their excess
production may result in tissue injury and inflammation (38). To combat these unrelenting
insults, the lungs have well coordinated and efficient endogenous antioxidant defense systems,
which protect against the injurious effects of oxidants by electron transfer, enzymatic removal,
scavenging and by keeping transition metal ions tightly sequestered. There are three major
classifications in the endogenous antioxidant defenses. i) Primary defense: It can prevent
radical formation. Transferrin and lactoferrin have this role in extracellular fluids. ii) Secondary
defense: It removes or inactivates formed ROS. This may be enzymes such as superoxide
dismutase, and glutathione peroxidase as well as non-enzymatic molecules such as reduced
glutathione, α-tocopherol, ascorbic acid, β-carotene, albumin, mucin, glucoase, bilirubin and
uric acid. iii) Tertiary defense: This system operates to remove and or repair oxidatively
damaged molecules, and is particularly important for proteins and deoxyribonucleic acids
(5). The lung has precise balance between the production/exposure of oxidants and endogenous
antioxidants. Oxidative stress resulting from an imbalanced ratio between ROS production and
detoxification plays an important role in cellular processes such as signal transduction and gene
expression (25). During acute and chronic inflammations, ROS is produced at rates that
overwhelm the capacity of the endogenous antioxidant defense system to remove it, resulting
in oxidative stress (25). Increased ROS production and reduced endogenous antioxidant
defense has been reported in several lung diseases including chronic obstructive pulmonary
disease (52,68,73). This may results in oxidative stress condition, which appears involved in
various chronic inflammatory lung disease pathogenesis.
ENDOGENOUS ROS PRODUCTION IN THE LUNG
Reactive oxygen and nitrogen species are generated by several inflammatory and structural
cells of the airways. A common feature of all inflammatory lung diseases is involvement of an
inflammatory-immune response, characterized by activation of epithelial cells, and resident
macrophages, and the recruitment and activation of neutrophils, eosinophils, monocytes, and
lymphocytes. Inflammatory cells once recruited in the airspace become activated and generate
ROS in response to a sufficient level of a secretagogue stimulus (threshold condition). The
activation of macrophages, neutrophils and eosinophils generates O2•-, which is rapidly
converted to hydrogen peroxide (H2O2) by superoxide dismutase (SOD), and hydroxyl radical
(•OH) formed non-enzymatically in the presence of Fe2+ as a secondary reaction. ROS can
also be generated intracellularly from several sources such as mitochondrial respiration, the
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NADPH oxidase system and xanthine/xanthine oxidase (65). At sites of inflammation,
increased free radical activity is associated with the activation of the neutrophil NADPH
oxidase and/or the uncoupling of a variety of redox systems, including endothelial cell xanthine
dehydrogenase (23,53).
ENVIRONMENTAL OXIDANTS
The air is polluted with cigarette smoke, automobile exhaust, diesel soot, ozone, sulfur dioxide,
nitrogen dioxide and varying degree of other pollutants produced by anthropogenic activities.
Due to the unique structure and function of the lung, it is vulnerable to numerous pathogens,
pollutants, oxidants, gases and toxicants that are inhaled continuously with ambient air.
Inhalation of such toxic pollutants and microorganisms results in lung injury and generation
of reactive oxygen/nitrogen species leading to cascades of signaling events triggering
inflammatory influx, production of proinflammatory cytokines, chemokines, and other factors
(21). Cigarette smoke is the major etiological factor in the pathogenesis of COPD (66). An
increased oxidant burden in smokers derives from the fact that cigarette smoke contains an
estimated 1017 oxidants/free radicals and 4,700 chemical compounds, including aldehydes and
quinines per puff, and many of those are relatively long-lived such as tar-semiquinone that can
generate •OH and H2O2 by Fenton reaction (14).
OXIDATIVE STRESS AND INFLAMMATION
Oxidative stress has been implicated in cell and tissue damage associated with many chronic
inflammatory lung diseases such as asthma, COPD, idiopathic pulmonary fibrosis (IPF) and
adult respiratory distress syndrome (ARDS) (1). Increased ROS production has been directly
linked to oxidation of protein, DNA, and lipids which may cause direct lung injury or induce
a variety of cellular responses through the generation of secondary metabolic reactive species.
The pathogenesis of many forms of lung injury has implicated peroxidative breakdown of
polyunsaturated fatty acids due to the effects on membrane function, inactivation of membrane-
bound receptors and enzymes, and increased tissue permeability (67). There is increasing
evidence that aldehydes, generated endogenously during the process of lipid peroxidation, are
involved in many of the pathophysiological events associated with oxidative stress in cells and
tissues (36). In addition to their cytotoxic properties, lipid peroxides are increasingly
recognized as being important in signal transduction for a number of important events in the
inflammatory response in the lungs (67).
ROS may alter the remodeling of extracellular matrix, apoptosis and mitochondrial respiration,
cell proliferation, maintenance of surfactant and the antiprotease screen, effective alveolar
repair responses and immune modulation in the lung (65,66). ROS produced by phagocytes
that have been recruited to sites of inflammation, are a major cause of the cell and tissue damage
associated with many chronic inflammatory lung diseases such as asthma, COPD, IPF and
ARDS. All these diseases involve the recruitment of immune and inflammatory cells to the
lungs. These cells are activated and produce mediators of inflammation including ROS and
cytokines, such as the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) (65).
OXIDATIVE STRESS AND CELL SIGNALING
There has been a paradigm shift in the belief that ROS may not always be detrimental and the
concept that ROS can be produced deliberately and act on specific targets to modulate signaling
pathways is gaining credence. In fact, the role of ROS as second messengers, in particular that
of H2O2, is gaining acceptance, as the four characteristics of classical second messengers,
i.e., regulated enzymatic production, degradation by specific enzymes, presence at low
concentrations that can be transiently elevated to measurable amounts upon stimulation, and
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(at least for H2O2) ability to react at specific sites, such as metals and thiolates, are now getting
support from studies with protein tyrosine phosphatases and other thiol-containing proteins.
The response of a cell or organism to an increase in ROS often involves the activation of
numerous intracellular signaling pathways. These cytosolic pathways can, in turn, regulate a
host of transcriptional changes that allow the cell to respond appropriately to the perceived
oxidative stress. In addition to the regulation achieved by classical cytosolic signaling
pathways, such as the family of mitogen-activated protein kinases, evidence suggests that
certain transcription factors can directly or indirectly alter their activity, depending on cellular
redox conditions (49). ROS such as hydrogen peroxide (H2O2) and oxygen free radicals are
implicated in the regulation and pathogenesis of inflammation. There is growing body of
evidence that ROS can be purposely made within cells to serve as signaling molecules (49,
67). Importantly, oxidants (ROS and RNS) produced by neutrophils participate as signaling
molecules that regulate diverse physiological signaling pathways in neutrophils. They also
serve as modulators of protein and lipid kinases, phosphatases, membrane receptors, ion
channels, and transcription factors, including NF-κB. The latter regulates expression of key
cytokines and chemokines that further modulate the inflammatory response (1).
Redox sensitive molecular targets usually contain highly conserved cysteine residues, and their
oxidation, nitration, and formation of disulfide links are crucial events in oxidant/redox
signaling. It is hypothesized that oxidation of those sulfide groups in signaling proteins causes
structural modifications, resulting in the exposure of active sites and protein activation. Such
molecular targets include transcription factors (NF-κB and AP-1), signaling molecules such
as ras/rac or c-Jun N-terminal kinase (JNK), protein tyrosine phosphatases and p21ras. Thiol
molecules such as intracellular reduced glutathione (GSH) and thioredoxin are of central
therapeutic importance in the regulated control of such redox signaling pathways, by reducing
disulfide bridges or oxidized cysteine residues (68). Recent studies have shown that in response
to TNF-α and lipopolysaccharide (LPS), which are relevant stimuli for the inflammatory
response in chronic inflammatory lung diseases, airway epithelial cells can concurrently
produce increased amounts of intracellular ROS. This intracellular production of oxidants and
the subsequent changes in intracellular redox status is important in the molecular events
controlling the expression of genes for inflammatory mediators. The signaling pathways and
activation of transcription factors in response to ROS is subject of rigorous investigation.
REDOX SIGNALING AND OXIDATIVE STRESS
At this juncture it would be prudent to differentiate redox signaling from oxidative stress.
Redox signaling involves at least one reaction of reversible oxidation of a signaling molecule
that is intended to modulate a signaling pathway, e.g. alteration of sulfhydryl group on protein
phosphatases as discussed above. On the other hand oxidative stress is often characterized as
an imbalance in the oxidant/antioxidant ratio, tilted toward a higher proportion of oxidants.
The ultimate outcome of oxidative stress is cell type specific, which can not only elicit
responses ranging from severe oxidative damage, loss of cell function and viability, to
apoptosis and ultimately necrosis, but may also induce responses such as cell differentiation
to cell cycle progression (2,60). Since both redox signaling and oxidative stress may occur
during different phases of inflammation, it is vital to understand the exact phenomenon that
underlies a pathologic state before designing a therapeutic strategy to counter the aberrations.
Also since cigarette smoke can elicit both redox and oxidative alterations (mainly
carbonylation) in a given type of a cell, it would be very vital to systematically delineate as to
which mechanistic and signaling pathway cigarette smoke alters. This knowledge would lead
to better understanding of the pathology due to cigarette smoke and would also lead to
development of a specific therapeutic agent.
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REDOX REGULATION OF NF-κB
NF-κB is a family of seven structurally related transcription factors (p50, p105, p52, p100,
RelA/p65, C-Rel and RelB) that play a central role in inflammation and stress response by
controlling gene network expression (30). The members of the NF-κB/Rel family of
transcription factors are known to activate expression of many pro-inflammatory genes
involved in lung inflammation (71). The expression of inflammatory mediators can be
regulated by the activation of redox-sensitive transcription factor, NF-κB, stimulated in
response to ROS (66) (Figure 2). In addition to ROS, cellular redox status, particularly thiol
status can be directly involved in activation of NF-κB, signal transduction and gene expression
involved in cellular pathophysiologic activities (66). Based on earlier studies with antioxidants
it was proposed that activation of NF-κB is redox-sensitive and is regulated by the changes in
the oxidant/antioxidant balance, further suggesting that agonists activating NF-κB, in particular
TNF-α, could stimulate the production of ROS (8,62).
Many proteins in the NF-κB pathway have reactive cysteines that impact on NF-κB activation.
Oxidation, nitration, and formation of disulfide links in cysteine residues of NF-κB are crucial
events in oxidant/redox signaling. Oxidation of these sulfhydryl groups may cause structural
modifications, resulting in the exposure of active site of the signaling protein and protein
activation (69). In addition to cysteine, other amino acids particularly those containing aromatic
rings, the thioester of methionine, and the protein backbone itself can also be oxidized, which
may impact signaling modules, such as NF-κB activation (17). While NF-κB subunits
themselves can be a target of oxidative regulation, upstream kinases of the NF-κB pathway are
also subject to redox regulation, and may in fact determine whether NF-κB will be activated
or inhibited in the presence of ROS. Many kinases (IKK, AKT/PI3K, MEKK-1 and various
nuclear kinases) involved in direct or indirect activation of NF-κB are affected by oxidants and
therefore, have the potential to alter NF-κB activity (62). Antioxidants, for instance, have been
reported to block NF-κB activation in certain cell types, leading to the hypothesis the activation
of this transcription factor is mediated by ROS in response to specific stimuli. A wide array of
antioxidants that can detoxify ROS/RNS have been reported to suppress the activation of NF-
κB signaling (37).
ROLE OF NF-κB in HISTONE MODIFICATIONS
The complex structure of chromatin consists of DNA wrapped around an octamer of core
histones, which is composed of two molecules each of the histones H2A, H2B, H3, and H4.
Nucleosomal DNA is dynamically packaged to varying degrees, resulting in different levels
of chromatin compaction ranging from the 10-nm fiber to higher order structures such as the
condensed mitotic chromosomes. Condensation of eukaryotic DNA in chromatin suppresses
gene activity through the coiling of DNA on the surface of the nucleosome core and folding
of nucleosome assemblies, thus decreasing the accessibility of transcriptional factors, such as
NF-κB (71,87). Alterations in the structure of chromatin are critical to the regulation of gene
expression (83). Gene expression is regulated by modifications such as acetylation of core
histones through the concerted action of coactivators such as CBP (cAMP-response element
binding protein-binding protein)/adenoviral protein E1A (p300), CBP/p300 associated factor
(P/CAF) and activating transcription factor-2 (ATF-2), which have intrinsic histone
acetyltransferase (HAT) activity and are able to recruit other HAT enzymes. Acetylation of
the ε-group on lysine (K) residues results in neutralization of positive charge on histone tails
that weakens the electrostatic interaction between the histone and the DNA backbone and
facilitates access to transcription factors (34). Increase in histone acetylation is therefore
associated with increased gene expression. Recent studies postulates that histone tails
themselves might participate directly in the binding of transcription factors, e.g., by virtue of
modified amino acids recognized by these factors (39). In addition, phosphorylation of histone
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is known as early step in chromatin remodeling and has been shown to be important during
chromosomal replication. Recently, this modification also has been found to be associated with
rapidly inducible pro-inflammatory gene promoters (32).
CBP/p300, transcriptional coactivators with intrinsic HAT activity, is regulated by p38 MAP
kinase pathway which is activated by oxidative stress condition (67). Kinase-mediated
phosphorylation of CBP/p300 has local effects on the conformation and activity. The additional
charge from the phosphate at Ser133 has been shown to increase the recruitment of CBP/p300
by forming hydrogen bonds with the Tyr658 and Lys662 residues in KIX domain (64,96).
Activation of CBP leads to acetylation of specific core histone lysine residues by an intrinsic
HAT activity. Acetylation of the histone tails presumably destabilizes the nucleosome, thereby
facilitating access by transcription factors and regulatory factors. Transcription coactivator,
p300 and CBP are reported to involve in the regulation of various DNA-binding transcriptional
factors (61). Like other transcription factors, NF-κB (RelA/p65) relies on the lysine acetylation
of histones by HAT to initiate DNA uncoiling and allow the accessibility for binding (12).
Thus histone acetylation via CBP/p300 has a significant role in the activation of NF-κB
mediated pro-inflammatory gene expression.
Repression of genes is associated with histone deacetylation, a process controlled by histone
deacetylases (HDACs). HDACs, conversely, act by catalyzing the removal of acetyl groups
on amino-terminal lysine (K) residues of histones, producing DNA rewinding and a condensed
chromatin structure, which results in transcriptional repression and gene silencing. Thus,
HDACs play an important role in maintaining the balance of histone acetylation/deacetylation
and/or transcriptional activity of pro-inflammatory genes in cells (67). Apart from the
inhibition of gene transcription, HDACs also directly affect the nuclear activity of transcription
factors such as NF-κB (12). HDACs not only deacetylate histones but also have the ability to
deacetylate non-histone proteins such as NF-κB and thereby have the ability to regulate NF-
κB dependent pro-inflammatory gene transcription (76). HDACs are known to regulate critical
cellular processes such as cell cycle progression and differentiation while HDAC inhibitors
are being studied as potential anti-cancer therapies since they induce apoptosis and cell cycle
arrest in certain transformed cell lines (56).
There are 18 potential deacetylase enzymes, HDAC1 to HDAC11 and Silent Information
Regulator (SIRT) SIRT1 to SIRT7, have been identified in humans (16,47). They are classified
into four classes: Class I HDACs include HDACs 1, 2, 3, 8 and are almost exclusively localized
to the nucleus depending on the presence or absence of a nuclear localization signal (NLS) and
a nuclear export signal (NES) (18). Members of this class are related to the yeast RPD3 protein.
Class II HDACs include HDACs 4–7, 9 and 10. These share similarities to the yeast HDAC1
and HDAC2 are thought to be able to shuttle between the nucleus and cytoplasm. However it
is thought that class II HDACs unlike members of the class I family are expressed in a cell
specific pattern suggesting they may play a role in specific cell functions. Class III HDACs
include SIRT 1–7 NAD+ family. It is suggested they may play a role in aging, inflammation
and cell senescence and possess non-histone protein substrates. Class IV HDACs include
HDAC 11 (18).
ROLE OF HDAC2 IN THE REGULATION OF NF-κB DEPENDENT GENES
Several reports have shown that HDACs 1–3 can also be associated with inactive RelA/p65
and play a role in the regulation of NF-κB-mediated gene transcription (3,12,95) (Table 1).
Thus, changes in HDAC activity associated with RelA/p65 can enhance or repress NF-κB-
mediated gene expression (95). Among several types of HDACs, HDAC2 is well characterized
and reported to play a role in the regulation of inflammation and has been implicated in the
dysregulation in smokers and patients with COPD (4,44,78). HDAC2 expression and activity
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is decreased in smokers, COPD subjects, and mild asthma patients and that there is a good
correlation between cytokine production and HDAC activity in alveolar macrophages from
smokers and non-smokers (1,4,44). Decreased levels/activities of HDAC2, i.e. disruption of
the acetylation:deacetylation balance, may lead to sustained transcription of pro-inflammatory
gene controlled by NF-κB, resulting in a chronic inflammatory response. Cigarette smoke
extract-mediated reduction in HDAC2 was associated with increased RelA/p65, and indicated
RelA/p65 interacts with HDAC2 and RelA/p65 becomes available or retained in the nucleus
for pro-inflammatory gene transcription when HDAC2 is decreased (88). In addition, we also
demonstrated HDAC3, but not HDAC1, interacted with RelA/p65, suggesting an important
role of specific HDACs such as HDAC2 and HDAC3 in regulation of NF-κB signaling pathway
particularly in response to cigarette smoke (88). The binding of NF-κB to HDAC2 presumably
reflects the recruitment of HDAC2 to specific NF-κB target promoters. The domains of
HDAC2 and NF-κB that interact remain to be identified. It is unlikely that this interaction
involves the DNA binding domain of NF-κB, because trichostatin A (TSA) treatment did not
significantly interfere with DNA binding (93).
HDAC2 has also been implicated in the anti-inflammatory effects of corticosteroids as ligand
bound steroid receptors recruit HDAC2 to promoters of pro-inflammatory genes leading to
deacetylation and transcriptional repression. However, a small proportion of severe asthmatics
who smoke and severe COPD patients exhibit unresponsiveness towards high doses of oral
corticosteroids. The current hypothesis indicates that cigarette smoke-induced oxidative stress
alters the basal HDAC2 response via post-translational modifications and an induced net loss
of HDAC2. The absence of HDAC2 or the presence of a defective HDAC2 protein may thus
explain the abnormal inflammatory response and corticosteroid inefficiency in patients with
COPD. Decreased HDAC2 protein expression and deacetylase activity observed in the
macrophage of COPD patients (15,42) is implicated in an impaired ability of dexamethasone
to inhibit basal cytokine release in alveolar macrophages from COPD patients compared to
casual smokers (16) (Figure 3). However while many studies have focused on establishing a
link between decreased HDAC2 expression and increased susceptibility to persistent
inflammation, little is known on how HDAC2 expression is regulated in response to cigarette
smoke-induced oxidative stress.
POST-TRANSLATIONAL MODIFICATIONS OF HDAC2 AND ITS IMPACT ON
TRANCRIPTIONAL REGULATION
Post-translational modifications of HDAC2 have recently been thought to be the primary
mechanism involved in decreased activity of HDAC2 particularly as observed in alveolar
macrophages and peripheral lung tissue from healthy smokers and patients with COPD as
compared to healthy non-smokers (42,54,88). The decrease in HDAC2 activity correlated with
increased production of inflammatory cytokines in the lung (42,88). Decreased HDAC2
activity was also observed in vitro experiments in monocytic cell lines treated with cigarette
smoke extract showing modifications by aldehydes and by protein nitration, and restoration of
HDAC2 activity by pre-treating the cells with GSH monoethyl ester (88). Synthetic nitric oxide
(NO)/peroxynitrite donors also increases nitrosylation of tyrosine residues on HDAC2 leading
to a decrease in deacetylase activity (41,54). Moreover, alveolar macrophages from COPD
patients show a marked increase in nitrosylation of HDAC2 (15). The results suggested that
oxidative stress may play a role in reduced activity of HDAC2 by post-translational
modification. Thus, several post-translational modifications to HDAC2 such as nitrosylation
and α-β unsaturated aldehyde-adduct formation (protein carbonyl-adducts) have been
implicated in the loss of deacetylase activity and as possible mechanisms for pro-inflammatory
response in patients with COPD (Figure 4).
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With the exception of mammalian HDAC8, recombinant HDACs are not enzymatically active
(40) and require a co-repressor complex that involves complex protein-protein interactions that
enhance their deacetylase activities or mediate their association with histones or DNA since
HDACs have no ability to bind DNA. HDAC2 is known to associate with three different co-
repressor complexes; Sin3, NuRD/Mi2 and the CoRest complexes (Figure 5). Both the Sin3
and Mi2 complexes contain a core group of four proteins HDAC1, HDAC2, RbAp46 and
RbAp48 including the distinct mSin3A protein in the Sin3 complex and Mi2 in the NuRD/Mi2
complex (76). RbAp48 is known to selectively bind to histone H4 in vivo (85), thus serving to
recruit HDAC2 to DNA. Since histone deacetylases where first discovered to be
phosphoproteins (82), an increasing body of evidence is elucidating mechanisms by which
HDAC2 is regulated by hyperphosphorylation. Galasinski et al first showed that HDAC2 exists
in three forms; the unphosphorylated, basally phosphorylated and hyperphosphorylated forms
(28). Hyperphosphorylation of HDAC2 induced by inhibiting cellular serine phosphatase
activity increased disruption of the HDAC2-mSin3A interaction (28); oxidative and nitrative
stress was also shown to reduce the Mi2/mSin3A interaction with HDAC2 without a reduction
in protein expression (29). In vitro phosphorylated flag-tagged HDAC2 showed a reduction in
deacetylase activity (82) indicating that hyperphosphorylation of co-repressor complex may
be one plausible explanation for decreased HDAC2 deacetylase activity in response to
oxidative stress. However the observation that hypophosphorylated HDAC2 disrupts
interaction with mSin3A/Mi2 (82) is further evidence of the complex mechanisms by which
phosphorylation regulates HDAC2. Site directed mutations of Ser421 and Ser423
phosphorylation sites in HDAC1 completely abolishes co-repressor complex formation (76).
Basal phosphorylation is required for its deacetylase activity, however, hyperphosphorylation
of HDAC2 has been shown to cause a dissociation of the co-repressor complex required for
deacetylase activity (28) (Figure 5).
Current theories on HDAC2 degradation has focused mainly on a possible role of the ubiquitin-
proteasomal pathway. Proteolytic degradation regulates the basal turnover HDAC2 and it is
currently hypothesized that hyperphosphorylation of HDAC2 may increase ubiquitination and
eventual net loss of HDAC2. Valproic acid, a potent inhibitor of HDACs, increases the
polyubiquitination of HDAC2, while the over-expression of the E2 ubiquitin ligase Ubc8
causes a decrease in HDAC2 protein expression (48). It remains to be seen whether oxidative
stress-induced hyperphosphorylation may regulate HDAC2 in a similar fashion. While protein
kinase A (PKA) is known to phosphorylate HDAC1, only casein kinase 2 (CK2) is known to
phosphorylate HDAC2 in vivo and in vitro (82). Oxidative stress-induced phosphoinositide-3
kinase (PI3K) activation has been shown to be involved in reducing HDAC2 activity (22);
other studies have shown a decreased inflammatory response to cigarette smoke exposure in
the PI3Kγ knock out mouse model (33) while PI3Kδ knock-in restored steroid function in a
mouse model of cigarette smoke exposure (53). However no direct link between PI3K and
hyperphosphorylation of HDAC2 has been established. Cigarette smoke is known to cause
increased HDAC2 phosphorylation. Since valproic acid, an HDAC2 inhibitor induces HDAC2
ubiquitination and proteasomal degradation (48), it is thought that cigarette smoke might
induce degradation of HDAC2 via the ubiquitin-proteasome pathway and that
hyperphosphorylation might be the trigger for this event. This contention of cigarette smoke-
mediated HDAC2 regulation by ubiquitin-proteasome pathway requires further investigation.
The loss of HDAC2 levels in the lung of COPD patients may also be a result of observed
reduction in HDAC2 mRNA expression (42). A recent study using a luciferase reporter system
linked to the HDAC2 promoter showed diminished promoter activation in response to hypoxia
and oxidative stress which was rescued by corticosteroids (10). Possible mechanisms may
involve deacetylation of critical histones in the promoter region or increased methylation of
DNA which has been linked to gene silencing. However, very little is known about HDAC2
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promoter regulation that may prove to be an important link to how cells respond to oxidative
stress.
ROLE OF HDAC1 and HDAC3 IN THE REGULATION OF NF-κB
HDAC1 (class I HDAC) is crucial in suppressing NF-κB dependent gene expression, including
and silencing of pro-inflammatory cytokine (IL-8) expression (3,95). Moreover, HDAC1
directly associates with the Rel homology domain of NF-κB p65 to alter its NF-κB activity in
cultured cells. HDAC2 may also regulate NF-κB activity through its association with HDAC1
(3). Recruitment of HDAC1 results in local histone H3 deacetylation, which facilitates the
closed chromatin complex formation and prevents the association of RNA polymerase II with
the promoter, leading to its repression (86). On stimulation, NF-κB with RelA/p65
phosphorylated possibly by PKA recruits CBP with intrinsic HAT activity and translocates to
the nucleus where it displaces the HDAC1/p50 complex to increase gene transcription (95).
Oxidative stress-mediated phosphorylation of RelA/p65 may lead to dissociation from HDAC1
and can then associate with CBP/p300 (88,95) which leads to expression of NF-κB mediated
pro-inflammatory gene expression. Oxidative stress may also cause post-translational
modifications of HDAC1 and prevent it from efficiently binding unstimulated RelA/p65, this
may predispose the cell to a higher NF-κB activation than would normally be possible.
HDAC3 functions as a co-repressor for many sequence-specific transcription factors, including
NF-κB. Through a physical interaction with transcription factors, HDAC3 is recruited to
specific promoters, where it brings about transcriptional repression through histone
deacetylation. In addition to this local function, HDAC3 is also important for global genome-
wide histone deacetylation and specific inactivation of HDAC3 leads to an increase in global
histone acetylation (31,94). HDAC3 associated with the acetyltransferases p300 and p300/
CBP-associated factor (PCAF) to reverse autoacetylation. Reversible deacetylation of the
inducible transcription factor NF-κB RelA by HDAC3 promotes effective binding to IκBα and
nuclear export of the complex to regulate target gene transcription (12).
Post-translational modification of histone proteins in chromatin architecture plays a central
role in the epigenetic regulation of transcription (1). Cigarette smoke is reported to decrease
the activity of HDAC and the levels of HDAC 1, 2 and 3, which are associated with the
significant increase in 4-hydroxy-2-nonenal (4-HNE) and nitrotyrosine post-translational
modification of HDAC proteins (41,88). This decline in HDAC1–3 protein was however
restored by pre-treating with GSH monoethyl ester suggesting a role for oxidative stress in
reduced HDAC activity (88). Since HDACs involved in the repression of pro-inflammatory
genes, activation of HDAC may have therapeutic potential, and theophylline has been shown
to have this property, resulting in marked potentiation of the anti-inflammatory therapy (45).
However, it is not known whether theophylline bypasses oxidative stress modifications or
inhibits phosphorylation of HDAC2 to restore steroid efficacy. Similarly, we have recently
shown that curcumin, a dietary polyphenolic antioxidant, reversed the steroid efficacy by
attenuating the CSE-induced reduction of HDAC2 in monocytes. This effect was not due to
curcumin’s antioxidant effect.
ROLE OF SIRTUIN (CLASS III HDAC) IN THE REGULATION OF NF-κB
Sirtuins (SIRT, Silent information regulator 2, Sir2 family of enzymes) belong to class III
HDACs that regulate gene expression in a variety of organisms by deacetylation of modified
lysine residues on histones, transcription factors and other proteins. SIRTs are widely
distributed in all phyla and are implicated in aging, cell cycle regulation, apoptosis, metabolism
and inflammation. SIRT include five homologues in yeast (ySir2 and Hst1–4) and seven in
humans (SIRT1–7, classes I – IV and U) (26). Unlike class I and II HDACs, which require
water molecule for deacetylation, sirtuins require NAD+ as a co-substrate. The stoichiometry
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between NAD+ and the substrate (acetylated protein) is 1:1 and the products of the reaction
are: 2-O-acetyl-ADP-ribose (ADPR), nicotinamide and deacetylated protein. The
deacetylating activity of sirtuins depends on NAD+ and is inhibited by the reaction product,
nicotinamide (IC50 <50 µM) (6). The other reaction product, O-acetyl-ADP-ribose is now
hypothesized to have signaling function (7).
Sirtuin1 (SIRT1) is an important mammalian sirtuin, predominantly present in the nucleus and
is homologous to yeast Sir2α(55). SIRT1 histone deacetylases bind directly to one or more
constituents in the chromatin complex resulting in structural re-organization, and therefore has
the ability to establish silent chromatin domains (24,79). The involvement of NAD+ in the
deacetylation reaction is also thought to link sirtuin deacetylase activity to metabolism (19).
SIRT1 control the energy metabolism and mediate the longevity effect of dietary caloric
restriction by activating gluconeogenesis and repressing glycolysis in the liver via
deacetylation of PPARγ coactivator-1 (PGC1). In addition, SIRT1 inhibits fat storage and
increases fat release in white adipose tissue via repression of PPARγ (35,63,74). In humans,
SIRT1 deacetylates transcription factors such as drosophila forkhead transcription factor
(FOXO), p53 and NF-κB, which mediates stress resistance, apoptosis, and inflammatory
responses that participate in physiological responses to toxicity (57,90). Since the
transcriptional activity of FOXO3 is regulated by phosphorylation and acetylation, SIRT1
mediated deacetylation of FOXO3 leads to its activation and induction of cell cycle arrest.
Thus high SIRT1 activity would promote cell survival (59,92). SIRT1 also upregulates stress-
positive pathways via deacetylation of FOXO3 transcription factor leading to increased
transcription of GADD45 (DNA repair) and MnSOD (reactive oxygen detoxification) (9,47).
Interestingly, SIRT1 interacts with p53 and deacetylates the C-terminal regulatory domain
(84), whereas reduction of SIRT1 leads to increased of acetylation of p53 thereby increasing
its pro-apoptotic and cell senescence function (50,84). Oxidative stress accelerates cellular
senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by
NAD+ depletion (27). Nuclear SIRT1 levels were decreased in vivo and in vitro in response to
cigarette smoke exposure (89), but it is not known if SIRT1-mediated regulation of FOXO3
(acetylation) plays a role in cigarette smoke-mediated apoptosis and senescence.
Recently, it has been shown that endogenous and exogenous SIRT1 were both able to partially
localize in cytoplasm in certain cell lines. Cytoplasm-localized SIRT1 enhances apoptosis
(46), whereas the nuclear form suppressed the oxidative stress-mediated apoptosis. Thus,
nucleocytoplasmic shuttling is important in the regulatory mechanism of SIRT1, which may
involve in differentiation and in inhibition of cell death (80). Evidence indicates that sirtuins
have evolved to mediate signaling initiated by stress condition such as nutrient deprivation to
produce adaptation to improve organism survival (35). SIRT1 regulates NF-κB-dependent
transcription and cell survival in response to TNF-α (11,84,89,91). SIRT1 protein associated
directly with RelA/p65 subunit of NF-κB and deacetylates Lys310 of RelA/p65, a site that
critical for NF-κB transcriptional activity, and thereby inhibit the activity of NF-κB (13,91).
Genetic ablation of SIRT1 leads to increased NF-κB activation and pro-inflammatory cytokine
release in mouse lung suggesting that SIRT1 knockdown leads to lung inflammation and
pulmonary edema (55). Similar to HDAC2, we have recently shown that decreased level of
SIRT1 in response to cigarette smoke extract was associated with increased activation of RelA/
p65 subunit of NF-κB and pro-inflammatory mediator release in human monocytic cell lines
(89). This may be partially explained on the basis that cigarette smoke-derived oxidants caused
post-transcriptional modification by reactive aldehydes/reactive oxygen species/reactive
nitrogen species, thereby disrupting SIRT1-RelA/p65 complex and increased the release of
pro-inflammatory mediators (89). Such oxidative/aldehyde/nitrosative modifications may in
turn render SIRT1 ineffective for interaction with other signaling components. Recently, Yang
et al have shown that resveratrol, a polypenolic antioxidant which induces SIRT1 activity,
attenuated CSE-induced pro-inflammatory cytokine release in monocytes (89). Overall, sirtuin
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is a redox-sensitive protein and prone to alterations by oxidants and/or free radicals, which in
turn linked with the abnormal regulation of various pro-inflammatory transcription regulatory
pathways.
CONCLUSIONS
ROS are critical in the pro-inflammatory response to cigarette smoke or other environmental
oxidants through the activation of NF-κB dependent redox-sensitive transcription factors and
alteration in histone acetylation/deacetylation balance (chromatin remodeling). ROS alters/
affects deacetylases such as HDAC 1,2,3 and SIRT1 (increased HAT/HDAC ratio) which leads
to acetylation of RelA/p65, disruption of HDAC-RelA/p65 complex and opening of chromatin
culminating in NF-κB dependent gene transcription. Oxidative stress-mediated post-
translational modifications (nitration, carbonylation or adduct formation) and phosphorylation
of HDACs and SIRT1 resulting in ubiquitination and proteosomal degradation. These post-
translational modifications will also lead to disruption of co-repressor complex, which is
essential for enzyme activity of HDAC2 and SIRT1. Since HDAC2 and its co-repressor
complex are involved in steroid efficacy, decreased HDAC2 or disruption of co-repressor
complex will cause steroid resistance which is seen in severe asthmatics and in patients with
COPD. Understanding the redox regulation of HDACs and their signaling mechanisms through
NF-κB will lead to better understanding of therapeutic targets and development of therapies
in chronic inflammatory lung diseases where oxidative stress occurs. Furthermore, these
mechanisms might be a key to overcome the limitations of glucocorticoid treatment in COPD
patients.
ACKNOWLEDGEMENTS
This work was supported by the NIEHS Environmental Health Sciences Center (ES01247), NIEHS Toxicology
Training Program Grant (ES07026), and National Institute of Health grant (R01-HL085613).
ABBREVIATIONS
AP-1, activator protein-1
AKT, protein kinase B/serine-threonine kinase
ATF-2, activating transcription factor-2
CBP, cAMP-response element binding protein-binding protein
COPD, chronic obstructive pulmonary disease
CoRest, co-repressor for element-1-silencing transcription factor
FOXO, fork-head box, class O protein
GADD45, growth arrest and DNA-damage-inducible protein 45
GSH, reduced glutathione
H2O2, hydrogen peroxide
HAT, histone acetyl transferase
HDAC, histone deacetylase
HNE, 4-hydroxyl-2-nonenol
IKK, inhibitor κB-α kinase
JNK, c-Jun N-terminal kinase
LPS, lipopolysaccharide
MAP, mitogen-activated protein
MEKK-1, extracellular signal-regulated kinase kinase
MnSOD, manganese superoxide dismutase
NAD, nicotinamide adenine dinucleotide
NADPH, reduced nicotinamide adenine dinucleotide phosphate
NF-κB, nuclear factor kappa B
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NuRD, nucleosome remodeling/histone deacetylase
O2•-, superoxide radical
•OH, hydroxyl radical
PI3K, phosphoinositide-3 kinase
PKA, protein kinase A
PPARγ, peroxisome proliferator-activated receptor-γ
RbAp, retinoblastoma-associated protein
ROS, reactive oxygen species
RNS, reactive nitrogen species
SIRT, silent information regulator
TNF-α, tissue necrosis factor-α
REFERENCES
1. Adcock IM, Ford P, Barnes PJ, Ito K. Epigenetics and airways disease. Respir Res 2006;7:21. [PubMed:
16460559]
2. Adler V, Yin Z, Tew KD, Ronai Z. Role of redox potential and reactive oxygen species in stress
signaling. Oncogene 1999;18:6104–6111. [PubMed: 10557101]
3. Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 (RelA) subunit of NF-kappaB interacts with
the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene
expression. Mol Cell Biol 2001;21:7065–7077. [PubMed: 11564889]
4. Barnes PJ, Ito K, Adcock IM. Corticosteroid resistance in chronic obstructive pulmonary disease:
inactivation of histone deacetylase. Lancet 2004;363:731–733. [PubMed: 15001333]
5. Bast A, Haenen GR, Doelman CJ. Oxidants and antioxidants: state of the art. Am J Med 1991;91:2S–
13S. [PubMed: 1928207]
6. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA. Inhibition of silencing and
accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol
Chem 2002;277:45099–45107. [PubMed: 12297502]
7. Borra MT, O'Neill FJ, Jackson MD, Marshall B, Verdin E, Foltz KR, Denu JM. Conserved enzymatic
production and biological effect of O-acetyl-ADP-ribose by silent information regulator 2-like NAD
+-dependent deacetylases. J Biol Chem 2002;277:12632–12641. [PubMed: 11812793]
8. Bowie A, O'Neill LA. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the
evidence in the light of recent discoveries. Biochem Pharmacol 2000;59:13–23. [PubMed: 10605930]
9. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R,
Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME.
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science
2004;303:2011–2015. [PubMed: 14976264]
10. Charron C, Adcock I, Barnes P, Ito K. HDAC2 promoter activation is diminished under hypoxia and
oxidative stress but enhanced by corticosteroid. American Journal of Respiratory and Critical Care
Medicine 2007;175:A112.
11. Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, Mucke L, Gan L. SIRT1 protects against
microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem
2005;280:40364–40374. [PubMed: 16183991]
12. Chen L, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-kappaB action regulated by
reversible acetylation. Science 2001;293:1653–1657. [PubMed: 11533489]
13. Chen LF, Mu Y, Greene WC. Acetylation of RelA at discrete sites regulates distinct nuclear functions
of NF-kappaB. Embo J 2002;21:6539–6548. [PubMed: 12456660]
14. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications.
Environ Health Perspect 1985;64:111–126. [PubMed: 3007083]
15. Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ. Theophylline restores histone
deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004;200:689–695.
[PubMed: 15337792]
Rajendrasozhan et al. Page 12
Antioxid Redox Signal. Author manuscript; available in PMC 2009 October 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
16. Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, Barnes PJ. Impaired inhibition
by dexamethasone of cytokine release by alveolar macrophages from patients with chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:24–31. [PubMed: 12406856]
17. Davies MJ. The oxidative environment and protein damage. Biochim Biophys Acta 2005;1703:93–
109. [PubMed: 15680218]
18. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases
(HDACs): characterization of the classical HDAC family. Biochem J 2003;370:737–749. [PubMed:
12429021]
19. Denu JM. Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent
deacetylases. Trends Biochem Sci 2003;28:41–48. [PubMed: 12517451]
20. Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA. Role for human SIRT2 NAD-
dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol 2003;23:3173–
3185. [PubMed: 12697818]
21. Emmendoerffer A, Hecht M, Boeker T, Mueller M, Heinrich U. Role of inflammation in chemical-
induced lung cancer. Toxicol Lett 2000;112–113:185–191.
22. Failla M, To Y, Ito M, Adcock I, Barnes P, Ito K. Oxidative stress-induced PI3-kinase activation
reduces HDAC activity and is inhibited by theophylline. Am J Respir Crit Care Med 2007;175:A45.
23. Fialkow L, Wang Y, Downey GP. Reactive oxygen and nitrogen species as signaling molecules
regulating neutrophil function. Free Radic Biol Med 2007;42:153–164. [PubMed: 17189821]
24. Fraga MF, Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet. 2007
25. Fridovich I. Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann
N Y Acad Sci 1999;893:13–18. [PubMed: 10672226]
26. Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like
proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem
Biophys Res Commun 1999;260:273–279. [PubMed: 10381378]
27. Furukawa A, Tada-Oikawa S, Kawanishi S, Oikawa S. H2O2 accelerates cellular senescence by
accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion. Cell
Physiol Biochem 2007;20:45–54. [PubMed: 17595514]
28. Galasinski SC, Resing KA, Goodrich JA, Ahn NG. Phosphatase inhibition leads to histone
deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem
2002;277:19618–19626. [PubMed: 11919195]
29. Getting S, Adcock I, Barnes P, Ito K. Reduced association of co-repressors under oxidative stress
reduces HDAC2 activity in airway epithelial cells. Am J Respir Crit Care Med 2007;175:A175.
30. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109:S81–S96. [PubMed:
11983155]
31. Glaser KB, Li J, Staver MJ, Wei RQ, Albert DH, Davidsen SK. Role of class I and class II histone
deacetylases in carcinoma cells using siRNA. Biochem Biophys Res Commun 2003;310:529–536.
[PubMed: 14521942]
32. Gloire G, Horion J, El Mjiyad N, Bex F, Chariot A, Dejardin E, Piette J. Promoter-dependent effect
of IKKalpha on NF-kappa B/p65 DNA binding. J Biol Chem. 2007
33. Grumelli S, Lu B, Shapiro S, Gerard C. Decreased inflammation in the smoking model of PI3K knock-
out mice. Am J Respir Crit Care Med 2007;175:A648.
34. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997;389:349–352.
[PubMed: 9311776]
35. Guarente L, Picard F. Calorie restriction--the SIR2 connection. Cell 2005;120:473–482. [PubMed:
15734680]
36. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem
1995;41:1819–1828. [PubMed: 7497639]
37. Haddad JJ. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive
transcription factors. Cell Signal 2002;14:879–897. [PubMed: 12220615]
38. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: where are we
now? J Lab Clin Med 1992;119:598–620. [PubMed: 1593209]
Rajendrasozhan et al. Page 13
Antioxid Redox Signal. Author manuscript; available in PMC 2009 October 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
39. Hildmann C, Riester D, Schwienhorst A. Histone deacetylases--an important class of cellular
regulators with a variety of functions. Appl Microbiol Biotechnol 2007;75:487–497. [PubMed:
17377789]
40. Hu E, Chen Z, Fredrickson T, Zhu Y, Kirkpatrick R, Zhang GF, Johanson K, Sung CM, Liu R, Winkler
J. Cloning and characterization of a novel human class I histone deacetylase that functions as a
transcription repressor. J Biol Chem 2000;275:15254–15264. [PubMed: 10748112]
41. Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IM. Oxidative stress reduces histone deacetylase
2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res
Commun 2004;315:240–245. [PubMed: 15013452]
42. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg
JC, Barnes PJ. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N
Engl J Med 2005;352:1967–1976. [PubMed: 15888697]
43. Ito K, Jazrawi E, Cosio B, Barnes PJ, Adcock IM. p65-activated histone acetyltransferase activity is
repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J Biol
Chem 2001;276:30208–30215. [PubMed: 11395507]
44. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM. Cigarette smoking reduces histone
deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in
alveolar macrophages. Faseb J 2001;15:1110–1112. [PubMed: 11292684]
45. Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ. A molecular mechanism of
action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene
expression. Proc Natl Acad Sci U S A 2002;99:8921–8926. [PubMed: 12070353]
46. Jin Q, Yan T, Ge X, Sun C, Shi X, Zhai Q. Cytoplasm-localized SIRT1 enhances apoptosis. J Cell
Physiol. 2007
47. Kobayashi Y, Furukawa-Hibi Y, Chen C, Horio Y, Isobe K, Ikeda K, Motoyama N. SIRT1 is critical
regulator of FOXO-mediated transcription in response to oxidative stress. Int J Mol Med
2005;16:237–243. [PubMed: 16012755]
48. Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B,
Bach I, Heinzel T, Gottlicher M. The histone deacetylase inhibitor valproic acid selectively induces
proteasomal degradation of HDAC2. Embo J 2003;22:3411–3420. [PubMed: 12840003]
49. Liu H, Colavitti R, Rovira II, Finkel T. Redox-dependent transcriptional regulation. Circ Res
2005;97:967–974. [PubMed: 16284189]
50. Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W. Acetylation of p53 augments its site-specific
DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A 2004;101:2259–2264. [PubMed:
14982997]
51. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W. Negative control of p53
by Sir2alpha promotes cell survival under stress. Cell 2001;107:137–148. [PubMed: 11672522]
52. MacNee W, Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 1999;160:S58–S65. [PubMed: 10556172]
53. Marwick J, Stevenson C, Koremu M, Barnes P, Ito K, Adcock I, Kirkham P. PI-3K-delta dead knock-
in restores steroid function in smoking mouse model. Am J Respir Crit Care Med 2007;175:A696.
54. Marwick JA, Kirkham PA, Stevenson CS, Danahay H, Giddings J, Butler K, Donaldson K, Macnee
W, Rahman I. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in
rat lungs. Am J Respir Cell Mol Biol 2004;31:633–642. [PubMed: 15333327]
55. McBurney MW, Yang X, Jardine K, Hixon M, Boekelheide K, Webb JR, Lansdorp PM, Lemieux
M. The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol Cell
Biol 2003;23:38–54. [PubMed: 12482959]
56. McLaughlin F, Finn P, La Thangue NB. The cell cycle, chromatin and cancer: mechanism-based
therapeutics come of age. Drug Discov Today 2003;8:793–802. [PubMed: 12946642]
57. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J
2007;404:1–13. [PubMed: 17447894]
58. Morcillo EJ, Estrela J, Cortijo J. Oxidative stress and pulmonary inflammation: pharmacological
intervention with antioxidants. Pharmacol Res 1999;40:393–404. [PubMed: 10527653]
Rajendrasozhan et al. Page 14
Antioxid Redox Signal. Author manuscript; available in PMC 2009 October 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
59. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente
L. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004;116:551–563. [PubMed:
14980222]
60. Nakajima Y, Aoshiba K, Yasui S, Nagai A. H2O2 induces apoptosis in bovine tracheal epithelial cells
in vitro. Life Sci 1999;64:2489–2496. [PubMed: 10403508]
61. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators
p300 and CBP are histone acetyltransferases. Cell 1996;87:953–959. [PubMed: 8945521]
62. Pantano C, Reynaert NL, van der Vliet A, Janssen-Heininger YM. Redox-sensitive kinases of the
nuclear factor-kappaB signaling pathway. Antioxid Redox Signal 2006;8:1791–1806. [PubMed:
16987032]
63. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M,
McBurney MW, Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing
PPAR-gamma. Nature 2004;429:771–776. [PubMed: 15175761]
64. Radhakrishnan I, Perez-Alvarado GC, Parker D, Dyson HJ, Montminy MR, Wright PE. Solution
structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for
activator:coactivator interactions. Cell 1997;91:741–752. [PubMed: 9413984]
65. Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and
molecular mechanisms. Cell Biochem Biophys 2005;43:167–188. [PubMed: 16043892]
66. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic
lung diseases. J Biochem Mol Biol 2003;36:95–109. [PubMed: 12542980]
67. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur
Respir J 2006;28:219–242. [PubMed: 16816350]
68. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir
J 2000;16:534–554. [PubMed: 11028671]
69. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung
inflammation: therapeutic approaches. Free Radic Biol Med 2000;28:1405–1420. [PubMed:
10924859]
70. Rahman I, MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax
1998;53:601–612. [PubMed: 9797762]
71. Rahman I, Marwick J, Kirkham P. Redox modulation of chromatin remodeling: impact on histone
acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem
Pharmacol 2004;68:1255–1267. [PubMed: 15313424]
72. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and
smokers. Am J Respir Crit Care Med 1996;154:1055–1060. [PubMed: 8887607]
73. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative
Stress Study Group. Am J Respir Crit Care Med 1997;156:341–357. [PubMed: 9279209]
74. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose
homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005;434:113–118. [PubMed:
15744310]
75. Senese S, Zaragoza K, Minardi S, Muradore I, Ronzoni S, Passafaro A, Bernard L, Draetta GF, Alcalay
M, Seiser C, Chiocca S. Role for histone deacetylase 1 in human tumor cell proliferation. Mol Cell
Biol 2007;27:4784–4795. [PubMed: 17470557]
76. Sengupta N, Seto E. Regulation of histone deacetylase activities. J Cell Biochem 2004;93:57–67.
[PubMed: 15352162]
77. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol
Med 1997;22:269–285. [PubMed: 8958153]
78. Szulakowski P, Crowther AJ, Jimenez LA, Donaldson K, Mayer R, Leonard TB, Macnee W, Drost
EM. The effect of smoking on the transcriptional regulation of lung inflammation in patients with
chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:41–50. [PubMed:
16574938]
79. Takata T, Ishikawa F. Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1
and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression. Biochem
Biophys Res Commun 2003;301:250–257. [PubMed: 12535671]
Rajendrasozhan et al. Page 15
Antioxid Redox Signal. Author manuscript; available in PMC 2009 October 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
80. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y. Nucleocytoplasmic shuttling of the NAD
+-dependent histone deacetylase SIRT1. J Biol Chem 2007;282:6823–6832. [PubMed: 17197703]
81. Trapp J, Jung M. The role of NAD+ dependent histone deacetylases (sirtuins) in ageing. Curr Drug
Targets 2006;7:1553–1560. [PubMed: 17100594]
82. Tsai SC, Seto E. Regulation of histone deacetylase 2 by protein kinase CK2. J Biol Chem
2002;277:31826–31833. [PubMed: 12082111]
83. Urnov FD, Wolffe AP. Chromatin remodeling and transcriptional activation: the cast (in order of
appearance). Oncogene 2001;20:2991–3006. [PubMed: 11420714]
84. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. hSIR2
(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001;107:149–159. [PubMed:
11672523]
85. Vermaak D, Wade PA, Jones PL, Shi YB, Wolffe AP. Functional analysis of the SIN3-histone
deacetylase RPD3-RbAp48-histone H4 connection in the Xenopus oocyte. Mol Cell Biol
1999;19:5847–5860. [PubMed: 10454532]
86. Wooten-Blanks LG, Song P, Senkal CE, Ogretmen B. Mechanisms of ceramide-mediated repression
of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone
deacetylase 1. Faseb J. 2007
87. Wu C. Chromatin remodeling and the control of gene expression. J Biol Chem 1997;272:28171–
28174. [PubMed: 9353261]
88. Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, Rahman I. Cigarette
smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational
modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol
2006;291:L46–L57. [PubMed: 16473865]
89. Yang SR, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I. Sirtuin regulates cigarette smoke-
induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in
rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol
Physiol 2007;292:L567–L576. [PubMed: 17041012]
90. Yang T, Sauve AA. NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in
stress and toxicity. Aaps J 2006;8:E632–E643. [PubMed: 17233528]
91. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. Modulation of NF-
kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J 2004;23:2369–
2380. [PubMed: 15152190]
92. You H, Mak TW. Crosstalk between p53 and FOXO transcription factors. Cell Cycle 2005;4:37–38.
[PubMed: 15611669]
93. Yu Z, Zhang W, Kone BC. Histone deacetylases augment cytokine induction of the iNOS gene. J
Am Soc Nephrol 2002;13:2009–2017. [PubMed: 12138131]
94. Zhang X, Wharton W, Yuan Z, Tsai SC, Olashaw N, Seto E. Activation of the growth-differentiation
factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3.
Mol Cell Biol 2004;24:5106–5118. [PubMed: 15169878]
95. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines
its association with CBP/p300 or HDAC-1. Mol Cell 2002;9:625–636. [PubMed: 11931769]
96. Zor T, Mayr BM, Dyson HJ, Montminy MR, Wright PE. Roles of phosphorylation and helix
propensity in the binding of the KIX domain of CREB-binding protein by constitutive (c-Myb) and
inducible (CREB) activators. J Biol Chem 2002;277:42241–42248. [PubMed: 12196545]
Rajendrasozhan et al. Page 16
Antioxid Redox Signal. Author manuscript; available in PMC 2009 October 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. ROS-mediated inflammation in the lung
Oxidative stress condition is produced in the lung by inhaled oxidants (external sources) and/
or release of ROS by the cellular sources. Inflammatory cells such as activated neutrophils
(PMNs), alveolar macrophages (AMs), eosinophils (Eos) are the most important cells involved
in endogenous generation of ROS. Intra and extra cellular generation of ROS lead to oxidant/
antioxidant imbalance and oxidation of biomolecules. ROS-mediated activation of NF-κB and
chromatin remodeling leads to up-regulated transcription of pro-inflammatory chemokine and
cytokine genes, and increased release of pro-inflammatory mediators which are involved in
the inflammatory responses in patients with COPD. ROS: Reactive Oxygen Species; RNS:
Reactive Nitrogen Species.
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Figure 2. Mechanism of ROS-mediated activation of NF-κB and pro-inflammatory gene
transcription
NF-κB exists as a heterodimeric complex of p50 and p65/RelA subunits. In the absence of
stimulation, NF-κB is found in the cytoplasm as an inactive, non-DNA binding form in
association with inhibitory κB (IκB). ROS are involved in the activation of NF-κB by redox
modulation of critical cysteine residue present on IκB kinase (IKK) subunit. Activation of NF-
κB involves the phosphorylation, ubiquitination, and subsequent proteolytic degradation of the
inhibitory protein IκB. Free/active NF-κB then translocate into the nucleus and binds with its
consenses sites which leads to the expression of pro-inflammatory genes. p50 and p65: Subunits
of NF-κB; ROS: Reactive Oxygen Species; P: Phosphate, Ub: Ubiquitin.
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Figure 3. Proposed mechanism of glucocorticoid resistance in COPD inflammation and the effect
of theophylline
Cigarette smoke-mediated oxidative stress activates the NF-κB pathway leading to acetylation
of chromatin on pro-inflammatory genes thus increasing the accessibility of transcription
factors leading to increased pro-inflammatory gene expression. Deacetylation results in DNA
rewinding around histone proteins, decreasing gene transcription. CBP/p300 function as
intrinsic histone acetyltransferases (HATs). Activated corticosteroid receptors recruit HDAC2
into the transcriptome complex promoting histone deacetylation, chromatin condensation and
expulsion of DNA polymerases, shutting off gene expression. Cigarette smoke/oxidants inhibit
HDAC2 activity (by post-translational modifications) as well as activating NF-κB, facilitating
histone acetylation by the transcriptome complex even in the presence of activated
glucocorticoid receptor. Theophylline, a methyl xanthine, inhibits pro-inflammatory gene
expression via restoring transrepressive pathways through the activation of HDAC2. GC:
Glucocorticoid; Ac: Acetylation; 4-HNE: 4-hydroxy-2-nonenol; NO2: Nitric oxide; P:
Phosphate; CBP: CREB (cAMP response element binding protein)-binding protein.
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Figure 4. Oxidant-mediated degradation of deacetylases (HDAC2/SIRT1) leading to increased
expression of pro-inflammatory cytokines
DNA is coiled around the histone proteins and form chromatin structure. Acetylation of
chromatin (on pro-inflammatory genes) increasing the accessibility of transcription factors and
there by increasing gene transcription. Deacetylation results in DNA rewinding around histone
proteins, and decreasing gene transcription. Thus, HDACs involved in the maintenance of
histone acetylation and deacetylation balance and thereby control the gene expression. HDAC
and/or SIRT1 may be post-translationally modified by phosphorylation, carbonylation,
aldehyde adducts formation and nitration leading to increased ubiquitination and subsequent
degradation of HDACs. Decreased HDACs leads to increased histone acetylation/
deacetylation ratio which cause increased acetylation of chromatin, chromatin remodulation
and increased transcription of pro-inflammatory mediators. HAT: Histone acetyltransferase,
HDAC: Histone deacetylase; P: phosphate; Ac: Acetylation; 4-HNE: 4-hydroxynonenol;
NO2: Nitric oxide.
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Figure 5. Proposed model for the regulation of HDAC2 co-repressor complex via phosphorylation/
dephosphorylation
HDAC2 can be phosphorylated by phospho kinase CK2 (PKCK2) and possibly by other
kinases, such as phosphoinositide-3 kinase (PI3K) and members of the mitogen-activated
protein (MAP) kinase family, and dephosphorylated by ser/thr phosphatase-dependent
mechanisms. Alteration in phosphorylation/dephosphorylation status can modify HDAC2
activity, particularly in response to cigarette smoke/oxidants exposure. The activity of HDAC2
relies on its association with co-repressor complexes (Sin 3A, NuRD/Mi2, N-CoR1/SMRT
and Co-REST). Post-translational modifications of HAC2 may have ramifications in sustained
inflammatory responses by the disruption of HDAC2 co-repressor complex. The mechanisms
that underlie cigarette smoke-mediated reductions in HDAC2 levels are not known, although
an attractive hypothesis is that it involves alterations in HDAC2 phosphorylation or inhibition
of ser-thr phosphatases may lead to subsequent ubiquitination and degradation of HDAC2 by
the 26S proteasome. A similar mechanism may be possible for SIRT1 and other HDAC
members. Ser-P: Phosphoserine; Thr-P: Phosphothreonine; ---→: disruption of HDAC2
complex.
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Table 1
Intracellular localization and functions of some of the deacetylases discussed in this review
Deacetylase Intracellular Localization Target Function Ref.
HDAC1 Nucleus Histone H1, and
p50 and RelA/
p65 subunits of
NF-κB
•Involved in cell proliferation (75)
•Interacts with p50 and RelA/p65 (12,95)
HDAC2 Cytoplasm and nucleus Histones,
glucocorticoid
receptor, RelA/
p65 and CBP/
p300
•Recruited by glucocorticoid on pro-
inflammatory genes
(4,43)
•Post-translationally modified by
oxidants/nitric oxide/carbonyls
(41,88)
•Interacts with RelA/p65 to inhibit
NF-κB transactivation
(88)
•Activated by theophylline (15,45)
•Phosphorylated and degraded (28,48,82)
HDAC3 Nucleus Histone H4 and
RelA/p65
•Interacts with RelA/p65 and inhibits
its transactivation
(12)
SIRT1 Cytoplasm and nucleus RelA/p65, p53
and FOXO3
•Interacts with RelA/p65 (89,91)
•Involved in regulation of pro-
inflammatory mediators (cytokines)
and MMPs
(57,89)
•Calorie restriction (6,35)
•Regulation of p53, FOXO3, DNA
repair, cell proliferation, cell cycle,
senescence and aging
(9,20,47,51,
59,81,84)
Activity of HDAC1, HDAC2 and HDAC3 is inhibited by trichostain A, sodium butyrate, valproic acid and suberoylanilide hydroxamic acid, whereas
SIRT1 activity is inhibited by sirtinol and nicotinamide adenine dinucleotide (NAD+), and activated by resveratrol.
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